Medu Group is proud to announce the acquisition of the Norwegian company Endotech, marking an important milestone in the Group’s continued expansion.

This transaction represents Medu Group’s ninth acquisition, further reinforcing its long-term strategy of building a strong, diversified platform of specialized companies.

Endotech brings deep technical expertise and a strong market position in Norway, making it a natural strategic fit for Medu Group. The acquisition supports Medu’s ambition to scale high-quality, technology-driven businesses while preserving local competence, culture, and operational excellence.

“Endotech is a well-run company with strong technical capabilities and a solid reputation in its market,” said Trond Dahl Hansen , COO of Medu Group. “This acquisition aligns perfectly with our strategy of partnering with companies that share our values and ambition for sustainable growth. We are excited to welcome Endotech to the Medu family.”

From a financial perspective, the acquisition reflects Medu Group’s disciplined and long-term approach to value creation.

“This is our ninth acquisition, and each one strengthens the Group both strategically and financially,” said Anders Kjøde , CFO of Medu Group. “Endotech adds complementary capabilities and strong cash-flow characteristics, supporting our goal of building a resilient and scalable group over time.”

Endotech will continue to operate under its existing brand and management, ensuring continuity for customers, employees, and partners.

With this acquisition, Medu Group continues to execute on its growth strategy and looks forward to further opportunities to expand its portfolio across the Nordic region.

https://endotech.no
https://medugroup.no